#ASCO23 Abs9117 #LCSM 🔬 Largest study yet showing upfront NGS testing leads to better OS compared to upfront non-NGS, later NGS, or no-NGS in aNSCLC 🧬. ➡️ Percentage of patients with upfront NGS increased from 29% in 2019 to 66% in 2022 📈. ➡️ Median OS longest in patients

Making progress! Still 1/3 of pts not getting NGS up front though, work to be done.

Most important tweet of the day in preparation for #ASCO23 - have you signed up for Sylvester Comprehensive Cancer Center #MiamiNights? umiamihealth.org/en/sylvester-c… OncoAlert ASCO #TrentSelfie

#ASCO23 Featured voices

This video echoes our mission to reimagine care so patients can #RedefineLiving, even in the face of a cancer diagnosis. It reminds us that, for some, time takes on an entirely new meaning– it becomes precious beyond measure. At The Janssen Pharmaceutica…lnkd.in/etuz32Wy

We're ready for another great #ASCO23. Cancelling Cancer One Step At A Time

COSMO at the ASCO TweetUp! @drdonsdizon Martina Murphy, MD #ASCO23 #COSMOCollab

Big thank you to Martina Murphy, MD @drdonsdizon Eleonora Teplinsky, MD, FASCO for a great COSMO meeting at #ASCO23 Nathan A. Pennell MD, PhD, FASCO Mike Thompson, MD, PhD, FASCO Mark Lewis, MD, FASCO Dr. Emily Drake Andrea Anampa-Guzmán (she/ella)

At The Janssen Pharmaceutical Companies of Johnson & Johnson, we are driven by our mission to reimagine care so patients can redefine living. #MyCompany  lnkd.in/ekAfA3PS

At #ASCO23, we’ve been showcasing our latest research and data in #LungCancer treatment. Our commitment in this space has led to exciting developments, including treatment options for previously difficult-to-treat forms of non-small cell lung cancer. If y…lnkd.in/euvuKkvX

This week at #ASCO23, The Janssen Pharmaceutical Companies of Johnson & Johnson shared the latest data on promising treatment options for #BladderCancer.  Big shout out to this incredible team! lnkd.in/e2Ut6ay9

Today I had the honor and the privilege to speak at the US Congressdotgov about #ProstateCancer. Once in a lifetime..

Yesterday, I had the honor of speaking to Congressional Men's Health Caucus about #ProstateCancer an issue that affects nearly 300,000 men in the U.S. each year, which means about one in 8 men will be diagnosed at some point in their life. And that number…lnkd.in/euGXhibi

#MedAffairsTalk: Digital Disruption and MA: Skills for the New Era x.com/i/broadcasts/1…

Reflecting on the past few weeks, I can’t help but feel grateful for the impactful engagements that Janssen and I have had the opportunity to take part in. #MyCompany   In early May, The Janssen Pharmaceutical Companies of Johnson & Johnson sponsored the…lnkd.in/g87t2DwC

#MedAffairsTalk: MA & Market Access: Value of Strategic Collaboration x.com/i/broadcasts/1…

At #ASCO23, JanssenUS submitted an abstract that evaluated how DEI hashtags are used during medical meetings. #MyCompany A key insight is how hashtags can expand engagement of DEI-focused conversations & bring awareness to #HealthDisparities. Read more: lnkd.in/e_R9iVPR

2023 Reflections: What We Learned and How to Make a Difference in Lung Cancer linkedin.com/pulse/2023-ref…

#MyCompany for US #HCPs new data in #LungCancer

Predictions for Pharma Medical Affairs in 2025. Buckle up—this isn’t your typical list. linkedin.com/pulse/predicti…